4.6 Article

Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

The mTOR pathway in hepatic malignancies

Mamatha Bhat et al.

HEPATOLOGY (2013)

Article Multidisciplinary Sciences

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

Russell A. Miller et al.

NATURE (2013)

Article Multidisciplinary Sciences

Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth

Heather A. Hirsch et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Oncology

Metformin targets ovarian cancer stem cells in vitro and in vivo

Jessica J. Shank et al.

GYNECOLOGIC ONCOLOGY (2012)

Article Gastroenterology & Hepatology

In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma

Zhan Qu et al.

HEPATOLOGY RESEARCH (2012)

Article Gastroenterology & Hepatology

Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation

Tsung-Ming Chen et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)

Review Oncology

Metformin: Taking away the candy for cancer?

Mathilde Jalving et al.

EUROPEAN JOURNAL OF CANCER (2010)

Article Surgery

Rapamycin Inhibits Proliferation and Migration of Hepatoma Cells In Vitro

Yasumasa Shirouzu et al.

JOURNAL OF SURGICAL RESEARCH (2010)

Article Gastroenterology & Hepatology

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease

Valter Donadon et al.

LIVER INTERNATIONAL (2010)

Article Gastroenterology & Hepatology

EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features

Taro Yamashita et al.

GASTROENTEROLOGY (2009)

Article Multidisciplinary Sciences

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations

Anna Dubrovska et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Gastroenterology & Hepatology

Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma

Augusto Villanueva et al.

GASTROENTEROLOGY (2008)

Article Medicine, General & Internal

Sorafenib in advanced hepatocellular carcinoma

Josep M. Llovet et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Oncology

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Jane E. Visvader et al.

NATURE REVIEWS CANCER (2008)

Article Multidisciplinary Sciences

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

Jiangbing Zhou et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Immunology

Human hepatic stem cells from fetal and postnatal donors

Eva Schmelzer et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2007)

Article Gastroenterology & Hepatology

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

Stephanie Ma et al.

GASTROENTEROLOGY (2007)

Review Medicine, General & Internal

Mechanisms of disease - Cancer stem cells

Craig T. Jordan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Multidisciplinary Sciences

Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

Omer H. Yilmaz et al.

NATURE (2006)

Article Medicine, General & Internal

Metformin and reduced risk of cancer in diabetic patients

JMM Evans et al.

BMJ-BRITISH MEDICAL JOURNAL (2005)

Review Oncology

Rapamycins - Mechanism of action and cellular resistance

SL Huang et al.

CANCER BIOLOGY & THERAPY (2003)

Article Medicine, Research & Experimental

Role of AMP-activated protein kinase in mechanism of metformin action

GC Zhou et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)